Search research articles
Contact Us
Filters
Showing results (181-190 of 187) with videos related to
Page
of 19
Sort By:
You have reached the last page of results.
This site can display upto 187 results.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 12, 2023
Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients-The European MelSkinTox study
J-M L'Orphelin, J Cassecuel, L Kandolf, et al.
Leukemia
|
January 28, 2017
Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia
C Rossig, M Pule, B Altvater, et al.
Annales De Dermatologie Et De Venereologie
|
July 20, 2004
[Relationship between clinical findings of patients with bullous pemphigoid and antigens recognized by their circulating antibasement membrane zone antibodies]
A Gary, P Carvalho, J-B Louison, et al.
Journal of the American Academy of Dermatology
|
June 1, 1997
Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials
W J Cunliffe, R Caputo, B Dreno, et al.
ESMO Open
|
November 16, 2016
Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study
R Gutzmer, L Rivoltini, E Levchenko, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 2, 2018
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort
M Kandel, C Allayous, S Dalle, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 21, 2013
Guidelines on the use of extracorporeal photopheresis
R Knobler, G Berlin, P Calzavara-Pinton, et al.
Page
of 19
Search research articles
Search
Showing results (181-190 of 187) with videos related to
Sort By:
Page
of 19
You have reached the last page of results.
This site can display upto 187 results.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 12, 2023
Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients-The European MelSkinTox study
J-M L'Orphelin, J Cassecuel, L Kandolf, et al.
Leukemia
|
January 28, 2017
Vaccination to improve the persistence of CD19CAR gene-modified T cells in relapsed pediatric acute lymphoblastic leukemia
C Rossig, M Pule, B Altvater, et al.
Annales De Dermatologie Et De Venereologie
|
July 20, 2004
[Relationship between clinical findings of patients with bullous pemphigoid and antigens recognized by their circulating antibasement membrane zone antibodies]
A Gary, P Carvalho, J-B Louison, et al.
Journal of the American Academy of Dermatology
|
June 1, 1997
Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials
W J Cunliffe, R Caputo, B Dreno, et al.
ESMO Open
|
November 16, 2016
Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study
R Gutzmer, L Rivoltini, E Levchenko, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 2, 2018
Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort
M Kandel, C Allayous, S Dalle, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 21, 2013
Guidelines on the use of extracorporeal photopheresis
R Knobler, G Berlin, P Calzavara-Pinton, et al.
Page
of 19